Search results
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 1 day agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Cameron Mathison Shares Heartfelt Post as His Daughter Leila Heads to Prom: ‘Always on My Mind and...
People Magazine· 6 days agoCameron Mathison shared a tender moment with his daughter Leila as she prepared to head off to her...
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 9 hours agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives $24.64 Average Target Price from Analysts
ETF DAILY NEWS· 5 days agoShares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are currently covering the stock, Marketbeat ...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 3 days agoCabometyx (cabozantinib) generated revenues of $376.4 million, which missed the Zacks Consensus...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Sutent Dosage: Form, Strengths, How to Take, and More
Healthline· 3 days agoSutent is a prescription drug used to treat certain types of cancer. Learn about the drug's dosages, form, strengths, how to take it, and more.
CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight
Benzinga· 3 days agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70